SynthesisEuropean journal of heart failure2022

Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.

Andrew J S Coats et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.